日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PARP1 Suppression Drives ROS Resistance in Aneuploid Cancer Cells

PARP1抑制驱动非整倍体癌细胞的ROS抵抗

Cheng, Pan; Mermerian-Baghdassarian, Angela; Wang, Yufeng; Chen, Ze; Quysbertf, Helberth M; Cheema, Pradeep Singh; Mays, Joseph C; Zhao, Xin; Katsnelson, Lizabeth; Mei, Sally; Shrivastava, Rohini; Bulatovic, Mirna; Deng, Jiehui; Schober, Markus; Wong, Kwok-Kin; Davoli, Teresa

Characterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data.

通过对多重成像数据进行无分割表示学习来表征肿瘤异质性

Tan Jimin, Le Hortense, Deng Jiehui, Liu Yingzhuo, Hao Yuan, Hollenberg Michelle, Liu Wenke, Wang Joshua M, Xia Bo, Ramaswami Sitharam, Mezzano Valeria, Loomis Cynthia, Murrell Nina, Moreira Andre L, Cho Kyunghyun, Pass Harvey I, Wong Kwok-Kin, Ban Yi, Neel Benjamin G, Tsirigos Aristotelis, Fenyö David

TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.

TNG260 是一种小分子 CoREST 抑制剂,可使 STK11 突变肿瘤对 PD-1 抗肿瘤免疫疗法敏感。

Ahronian Leanne G, Sahu Soumyadip, Zhang Minjie, Patel Ayushi S, Geng Ke, Bhattacharya Reshmee, Falchook Gerald S, Goldman Jonathan W, Spira Alexander I, Punekar Salman R, Spigel David R, Wang Judy S, Skoulidis Ferdinandos, Stephens Janaye, Meynardie Mary, Powell Jaylen M, Lopez Alfonso, Ranieri Michela, Ploszaj Magdalena A, Tan Yi Jer, Lee Yeuan Ting, Yu Yi, Deng Jiehui, Chen Ting, McCarren Patrick, Tsai Alice, Hussain Suleman S, Doyon Brian, Amemiya Kenjie, Ermolieff Jacques, Shahagadkar Preksha, Das Nikitha M, Flynn Lauren R, Shields Julie A, Danielczyk Laney, McMillan Brian J, Mignault Andre, Meier Samuel R, Wu Hsin-Jung, Guerin David J, Whittington Douglas A, Min Chengyin, Sienczylo Iga, Maxwell John P, DiBenedetto Heather J, Watanabe Hideo, Haines Brian B, Huang Alan, Crystal Adam, Andersen Jannik N, Wu Xinyuan, Wong Kwok-Kin

Tumor Cell Plasticity in Cancer: Signaling Pathways and Pharmaceutical Interventions

肿瘤细胞可塑性:信号通路和药物干预

Sun, Shangwei; Sun, Yunwei; Lan, Ling; Luan, Siyuan; Zhou, Jin; Deng, Jiehui; Yuan, Yong; Wu, Zhong

Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945.

深度突变扫描揭示了 EGFR 突变,这些突变赋予了对第四代 EGFR 酪氨酸激酶抑制剂 BLU-945 的耐药性

Wang Yueyang, Hao Yuan, Ranieri Michela, Abramyan Tigran M, Tsidilkovski Lev, Hollenberg Michelle, Lopez Alfonso, Moore Xavier T R, Sherman Fiona, Deng Jiehui, Saribekyan Hayk, Papoian Garegin, Wong Kwok-Kin, Shum Elaine, Poirier John T

Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors

达唑替纳联合帕博利珠单抗治疗接受低分割放射治疗的特定晚期实体瘤患者的 1b 期研究

Cooper, Benjamin T; Iams, Wade T; Page, David B; Yuan, Yuan; Gerber, Naamit K; Luke, Jason J; Gibbs, John P; Gregory, Richard C; Wong, Kwok-Kin; Deng, Jiehui; Perera, Samanthi A; Ding, Kai; Roberts, Emily R; Berger, Allison; Christensen, Camilla L; Tong, Erica Xin; Maldonado López, Angel E; Appleman, Vicky A; Leonard, E Jane; Parent, Alexander; Huang, Yu-Chung; Bay, Camden; Li, Cong; Lineberry, Neil; Raizer, Jeffrey; Olson, Daniel J; Chmura, Steven J

Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB-mediated inflammatory response in Triple Negative Breast Cancer.

靶向 DNA 聚合酶 Epsilon 可清除三阴性乳腺癌中的肿瘤并激活 NF-κB 介导的炎症反应。

Sher Elizabeth F, Fujihara Kenji M, Tao Anthony, Erenburg Diana, Sviderskiy Vladislav O, Mir Hannan, Karakousi Triantafyllia R, Loomis Cynthia, Deng Jiehui, Wong Kwok-Kin, Possemato Richard

Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy.

用于靶向癌症治疗的DNA损伤化学诱导剂邻近诱导剂(DD-CIP)的设计与开发。

Qiu Tian, Lee Yeuan Ting, Dwyer Brendan G, Tan Yi Jer, Chen Ting, Romero Bryan A, Wang Yanlan, Deng Jiehui, Zhang Tinghu, Crabtree Gerald R, Hinshaw Stephen M, Wong Kwok-Kin, Gray Nathanael S

Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer

Kras突变型肺癌中放射疗法与PD-1阻断的协同作用

Herter-Sprie, Grit S; Koyama, Shohei; Korideck, Houari; Hai, Josephine; Deng, Jiehui; Li, Yvonne Y; Buczkowski, Kevin A; Grant, Aaron K; Ullas, Soumya; Rhee, Kevin; Cavanaugh, Jillian D; Neupane, Neermala Poudel; Christensen, Camilla L; Herter, Jan M; Makrigiorgos, G Mike; Hodi, F Stephen; Freeman, Gordon J; Dranoff, Glenn; Hammerman, Peter S; Kimmelman, Alec C; Wong, Kwok-Kin

A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumors

STAT3 DNA结合的必要性阻止了肿瘤中NF-κB介导的Th-1免疫刺激基因的表达。

Lee, Heehyoung; Deng, Jiehui; Xin, Hong; Liu, Yong; Pardoll, Drew; Yu, Hua